Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy

Nancy Broos,Leiah J. Brigitha,Annemieke Schuurhof, Heike Röckmann-Helmbach,Wim J.E. Tissing,Rob Pieters,Inge M. van der Sluis, Marike B. Stadermann

EJC Paediatric Oncology（2023）

引用 0|浏览4

暂无评分

摘要

•Children with a PEG-asparaginase allergy can be safely vaccinated against COVID-19.•Irrespective of IgG/IgM antibodies to PEG-asparaginase.•Skin prick testing in PEG-asparaginase allergy does not seem to be of added value.

查看译文

关键词

PEG-Asparaginase,Polyethylene glycol,COVID-19 vaccine,Allergy,Paediatric,Antibodies

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要